Inflammatory manifestations of experimental lymphatic insufficiency - Wikidata - awgldk - TriplyDB

Inflammatory manifestations of experimental lymphatic insufficiency

Inflammatory manifestations of experimental lymphatic insufficiency

http://www.wikidata.org/entity/Q34770407

about

Adrenomedullin signaling is necessary for murine lymphatic vascular development.Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function Topical tacrolimus for the treatment of secondary lymphedema.A new mouse model to study acquired lymphedema IL-6 regulates adipose deposition and homeostasis in lymphedema.Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema.Lymphangiogenesis: a new player in cancer progression.Spatio-temporal changes of lymphatic contractility and drainage patterns following lymphadenectomy in mice.Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair.Blood and lymphatic vasculature in the ovary: development, function and disease.CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis.Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel Leukotriene B4 antagonism ameliorates experimental lymphedema.Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.Bridging the divide between pathogenesis and detection in lymphedema.Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function?Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow.Higher vascular endothelial growth factor-C concentration in plasma is associated with increased forearm capillary filtration capacity in breast cancer-related lymphedema.Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation.Galectin-1 regulates tissue exit of specific dendritic cell populations.Physiotherapeutic stimulation: Early prevention of lymphedema following axillary lymph node dissection for breast cancer treatment.Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis Systemic and global toxicities of head and neck treatment.Biomarkers of lymphatic function and disease: state of the art and future directions.Adrenomedullin haploinsufficiency predisposes to secondary lymphedema.Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model Differential transport function of lymphatic vessels in the rat tail model and the long-term effects of Indocyanine Green as assessed with near-infrared imaging.New developments in clinical aspects of lymphatic disease.Minimally invasive method for determining the effective lymphatic pumping pressure in rats using near-infrared imaging.Inflammatory Manifestations of Lymphedema.Current concepts and future directions in the diagnosis and management of lymphatic vascular disease.Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly?The inflammatory response of lymphatic endothelium.An immunological fingerprint differentiates muscular lymphatics from arteries and veins.Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.

P2860

Q24671300-E90C025C-1461-4D8F-9177-763F2323A923 Q27334274-130EE674-04A1-43DA-A871-0A02EED21A30 Q28472242-D0891F2C-C1AC-4658-851B-CBDAC247F7BF Q30819489-22AAE611-6B89-4C54-8F5F-E388842C74C4 Q30838687-A80477A5-0067-488C-A9B1-97B0EFB1D9E7 Q33250209-60CD8962-7DF0-48E5-8D72-470A03104594 Q33626518-1DD9B8EE-628F-4412-82DF-16E9A5905BDB Q33913140-1D64F92F-479D-49D0-BE7D-5EC090DE2020 Q34084937-FD32E74A-BD7C-4E87-BF52-D8B994B1B17F Q34110297-C1F10F7B-1EF6-40F7-9AA9-BEA4D7BCC654 Q34358339-00BADEBE-F440-4914-B441-08D8A5F67BC3 Q34375633-E0307755-4F12-4F0A-A1B7-0679AF07140A Q34490750-458F283A-6EF5-4B3E-8328-0B5585B0E4EB Q34525884-566EE26B-59C4-4C07-918B-A11B6713BFA5 Q34556483-C92D6E0A-3BE1-485E-8661-E70A004E3CEC Q34947505-8C85DBD3-6F0A-4C6D-8A6A-4573404C6993 Q34979277-A23CD5F7-346F-48F2-87AB-CA857DA39E43 Q35566114-7E9D7C41-A1A7-4465-AAEB-A742673FBEE4 Q35624894-7F0247EF-DB6F-4CA5-8792-F3AEF24C4AB3 Q35850300-698485F7-9B56-4E53-955C-47006E3846B3 Q35877534-4CDDAFAD-CEF1-469A-B9CE-BBCEB135C56C Q35890970-1CE9B875-CD3C-4B13-801D-61A058E00084 Q36049988-2BF8EAC6-3E12-4714-B8C2-62C9A79D7C94 Q36375209-6EB0FCDF-1C82-4F93-814B-D6DC1820930B Q36615191-5883D234-95AB-4E13-876B-D57F9281A1FC Q36732040-371B19E2-C870-4129-AF85-F222F17B7A91 Q36879176-E4825E21-50C3-4FFF-9C44-B7922C5B312E Q36913026-6CC9ADA7-8D5F-42C0-9CD6-EF4CFAFABB2E Q36928498-73B0A9EF-EFD6-45BE-A994-0205EEF6442D Q36954052-58E33CE7-1CE7-49A8-86FC-8AC0160EB9B5 Q37096518-26FB8E5A-E707-4F8F-868A-C92F1E714BD1 Q37609636-8CDD0668-2C82-4AC7-BFF3-CCA6F3EDBCDB Q37629285-6EF3D5E8-2481-4AEF-BFFE-3243FFADCC58 Q37631642-06AFE987-B565-4C9E-8FD5-FC3079054635 Q37756342-35515B0D-CEEC-4AC9-B9A9-3AA6F2DB1ECD Q37781426-AAC00890-D9EE-466D-8E13-AB39B154CB9B Q38010172-7C2E0C66-1156-40E0-8452-7FD424AB8E61 Q38155100-BCA06BF5-3A83-4AFE-A025-B56420C317E0 Q38452828-D5C86CD4-76AD-4694-AC5D-52479CC47353 Q38648224-53612980-7412-45DA-898F-83D5165D3ED5

P2860

Inflammatory manifestations of experimental lymphatic insufficiency

http://www.wikidata.org/entity/Q34770407

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Inflammatory manifestations of experimental lymphatic insufficiency

@ast

Inflammatory manifestations of experimental lymphatic insufficiency

@en

Inflammatory manifestations of experimental lymphatic insufficiency

@nl

type

label

Inflammatory manifestations of experimental lymphatic insufficiency

@ast

Inflammatory manifestations of experimental lymphatic insufficiency

@en

Inflammatory manifestations of experimental lymphatic insufficiency

@nl

prefLabel

Inflammatory manifestations of experimental lymphatic insufficiency

@ast

Inflammatory manifestations of experimental lymphatic insufficiency

@en

Inflammatory manifestations of experimental lymphatic insufficiency

@nl

P1433

Q34770407-EA17D4BD-B96D-44B6-BB55-B2D1DE499512

P1476

Q34770407-0E497F29-D052-4CE0-8623-E12838F69827

P2093

Q34770407-133151D8-7D8E-4B64-9FA0-97E583FFC330

Q34770407-1D5F15A4-47BA-4D6F-9E9F-3FC39484DB6F

Q34770407-28F0BB8E-58E6-4E1E-94DB-8CF2ECAC69C5

Q34770407-35CBFAE8-7122-469C-97BD-08936BD0858D

Q34770407-6A0E390A-4685-4A1F-BCBF-CCE8C87FD4C7

Q34770407-70732E60-2A6A-453B-9BC3-E89D08C918C3

Q34770407-7898B1BA-21BD-422B-93D9-3BAEB60C77DE

Q34770407-7C415C2D-05D5-4972-8F7A-F87D4984E967

Q34770407-9588C696-74CC-4277-B944-AE8B4FAAFAE4

Q34770407-BFAA73C6-58E6-4E52-AA12-415BB0AE2A71

P2860

Q34770407-04D916F7-06F9-47F4-A4CD-B62108977F77

Q34770407-04FB1484-5761-45B9-8C3E-4F092EF3F1AB

Q34770407-051AC2A4-0BC9-48E4-9C9B-ACF8763D8F18

Q34770407-0A716373-1AEB-447E-8785-AD189F627D2C

Q34770407-123A7E1D-D3CF-4A98-B80C-1F832325ED6F

Q34770407-128797AD-6E1A-4EA8-B19B-C6FCBBB9DA27

Q34770407-1388CD1E-7891-4BD7-A24C-2EBE4851441E

Q34770407-15358533-58DE-4DE4-981A-D04F983D2547

Q34770407-19913BBF-0FB9-48BD-B99B-736C0E7360E2

Q34770407-21B123AB-7792-4883-B5C5-B7064401B6A7

P304

Q34770407-BF500F93-D0ED-4576-82CF-43841E7071C8

P31

Q34770407-D50352AD-9D3E-47A6-B3F6-AC8226C97D7C

P356

Q34770407-6E40442B-F14A-4FD6-83A0-704C8BFFAC08

P407

Q34770407-CC48A9B2-3610-4205-8DEA-1F1482A900BA

P433

Q34770407-5CCCC649-DBE9-4A9B-AB72-6730E1D29735

P478

Q34770407-19DFA80D-C723-43B8-B69D-8E3456AFBFD7

P50

Q34770407-29579333-5B9B-4FA9-B933-7E6CE3463DC0

P577

Q34770407-C8B7DBFB-BF05-4753-B641-314D9A29056E

P5875

Q34770407-CDA52F9E-E7C7-452C-8AB8-6A3A718E9E4F

P698

Q34770407-9597C1D5-FE81-417A-97DA-DD8B74397725

P921

Q34770407-9A306402-86C7-43EA-9F8F-128CCF060403

P932

Q34770407-F6B25EB3-3F82-4174-A42F-E59572DC7F2E

P356

JOURNAL.PMED.0030254

P1433

P1476

Inflammatory manifestations of experimental lymphatic insufficiency

@en

P2093

Andreas Beilhack

http://www.w3.org/2001/XMLSchema#string

Andrew An

http://www.w3.org/2001/XMLSchema#string

Jeffrey Swanson

http://www.w3.org/2001/XMLSchema#string

Jennifer Han

http://www.w3.org/2001/XMLSchema#string

Lauren Cheung

http://www.w3.org/2001/XMLSchema#string

Ned Rockson

http://www.w3.org/2001/XMLSchema#string

Raymond Tabibiazar

http://www.w3.org/2001/XMLSchema#string

Roger Wagner

http://www.w3.org/2001/XMLSchema#string

Smita Joshi

http://www.w3.org/2001/XMLSchema#string

Soheil S Dadras

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Gene ontology: tool for the unification of biology

Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion

Significance analysis of microarrays applied to the ionizing radiation response

Identifying biological themes within lists of genes with EASE

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Tenascins: regulation and putative functions during pathological stress

Missing value estimation methods for DNA microarrays

A cell-free binding assay maps the LSP1 cytoskeletal binding site to the COOH-terminal 30 amino acids

Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C

P304

e254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.0030254

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Raymond Tabibiazar

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6952114

http://www.w3.org/2001/XMLSchema#string

P698

16834456

http://www.w3.org/2001/XMLSchema#string

P921

P932

1502157

http://www.w3.org/2001/XMLSchema#string